Hillrom Holdings Inc. is a global medical technology leader whose 10,000 employees have a single purpose: enhancing outcomes for patients and their caregivers by Advancing Connected Care™. Around the world, its innovations touch over 7 million patients each day. They help enable earlier diagnosis and treatment, optimize surgical efficiency and accelerate patient recovery while simplifying clinical communication and shifting care closer to home. The company makes these outcomes possible through connected smart beds, patient lifts, patient assessment and monitoring technologies, caregiver collaboration tools, respiratory health devices, advanced operating room equipment and more, delivering actionable, real-time insights at the point of care.
Company profile
Ticker
HRC
Exchange
Website
CEO
John Groetelaars
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
HILLENBRAND INDUSTRIES INC
SEC CIK
Corporate docs
Subsidiaries
Eagle Acquisition Sub B.V. • Hill-Rom, Inc. • Welch Allyn, Inc. • Advanced Respiratory, Inc. • Allen Medical Systems, Inc. • Hillrom Global Sourcing LLC • Hill-Rom Services, Inc. • Voalte, Inc. • Breathe Technologies, Inc. • Bardy Diagnostics, Inc. ...
IRS number
351160484
HRC stock data
Latest filings (excl ownership)
15-12B
Securities registration termination
23 Dec 21
10-K/A
2021 FY
Annual report (amended)
23 Dec 21
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Dec 21
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Dec 21
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Dec 21
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Dec 21
8-K
Creating ~$15 Billion Global Medtech Leader
13 Dec 21
25-NSE
Exchange delisting
13 Dec 21
8-K
Hillrom Shareholders Approve Acquisition By Baxter
3 Dec 21
DEFA14A
Additional proxy soliciting materials
23 Nov 21
Transcripts
HRC
Earnings call transcript
2021 Q3
30 Jul 21
HRC
Earnings call transcript
2021 Q2
30 Apr 21
HRC
Earnings call transcript
2021 Q1
5 Feb 21
HRC
Earnings call transcript
2020 Q4
6 Nov 20
HRC
Earnings call transcript
2020 Q3
31 Jul 20
HRC
Earnings call transcript
2020 Q1
1 May 20
HRC
Earnings call transcript
2020 Q1
24 Jan 20
HRC
Earnings call transcript
2019 Q4
1 Nov 19
HRC
Earnings call transcript
2019 Q3
2 Aug 19
HRC
Earnings call transcript
2019 Q2
26 Apr 19
Latest ownership filings
Financial summary
| Quarter (USD) | Sep 21 | Jun 21 | Mar 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Sep 21 | Sep 20 | Sep 19 | Sep 18 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 271.80 mm | 271.80 mm | 271.80 mm | 271.80 mm | 271.80 mm | 271.80 mm |
| Cash burn (monthly) | 233.33 k | 2.06 mm | (no burn) | (no burn) | (no burn) | (no burn) |
| Cash used (since last report) | 4.75 mm | 41.95 mm | n/a | n/a | n/a | n/a |
| Cash remaining | 267.05 mm | 229.85 mm | n/a | n/a | n/a | n/a |
| Runway (months of cash) | 1144.5 | 111.7 | n/a | n/a | n/a | n/a |
Institutional ownership, Q4 2022
| 13F holders | Current |
|---|---|
| Total holders | 0 |
| Opened positions | 0 |
| Closed positions | 1 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 0.00 |
| Total shares | 0.00 |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 13 Dec 21 | Mary Garrett | Common Stock | Sale back to company | Dispose D | No | No | 0 | 300 | 0.00 | 0 |
| 13 Dec 21 | Mary Garrett | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 1,798 | 0.00 | 0 |
| 13 Dec 21 | Mary Garrett | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 1,870 | 0.00 | 0 |
| 13 Dec 21 | Mary Garrett | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 1,762 | 0.00 | 0 |
| 13 Dec 21 | Mary Garrett | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 2,184 | 0.00 | 0 |
| 13 Dec 21 | Mary Garrett | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 2,762 | 0.00 | 0 |
| 13 Dec 21 | Barbara W. Bodem | Common Stock | Sale back to company | Dispose D | No | No | 0 | 14,039.759 | 0.00 | 0 |
| 13 Dec 21 | Barbara W. Bodem | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 13,951 | 0.00 | 0 |
| 13 Dec 21 | Barbara W. Bodem | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 3,026 | 0.00 | 0 |
| 13 Dec 21 | Barbara W. Bodem | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 1,253 | 0.00 | 0 |